LCM Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
9,878
+23
| +0.2% | +$1.07K | 0.24% | 58 |
|
|
2025
Q1 | $601K | Sell |
9,855
-66
| -0.7% | -$4.03K | 0.35% | 43 |
|
|
2024
Q4 | $561K | Buy |
9,921
+35
| +0.4% | +$1.98K | 0.32% | 47 |
|
|
2024
Q3 | $512K | Buy |
9,886
+44
| +0.4% | +$2.28K | 0.29% | 47 |
|
|
2024
Q2 | $409K | Buy |
9,842
+12
| +0.1% | +$498 | 0.25% | 53 |
|
|
2024
Q1 | $533K | Sell |
9,830
-113
| -1% | -$6.13K | 0.34% | 45 |
|
|
2023
Q4 | $510K | Sell |
9,943
-198
| -2% | -$10.2K | 0.37% | 44 |
|
|
2023
Q3 | $589K | Buy |
10,141
+97
| +1% | +$5.63K | 0.48% | 39 |
|
|
2023
Q2 | $642K | Buy |
10,044
+9
| +0.1% | +$576 | 0.52% | 36 |
|
|
2023
Q1 | $696K | Buy |
10,035
+239
| +2% | +$16.6K | 0.61% | 34 |
|
|
2022
Q4 | $705K | Buy |
9,796
+16
| +0.2% | +$1.15K | 0.69% | 27 |
|
|
2022
Q3 | $695K | Sell |
9,780
-19
| -0.2% | -$1.35K | 0.73% | 25 |
|
|
2022
Q2 | $755K | Sell |
9,799
-254
| -3% | -$19.6K | 0.74% | 27 |
|
|
2022
Q1 | $734K | Buy |
10,053
+57
| +0.6% | +$4.16K | 0.59% | 33 |
|
|
2021
Q4 | $623K | Buy |
9,996
+145
| +1% | +$9.04K | 0.48% | 38 |
|
|
2021
Q3 | $583K | Sell |
9,851
-163
| -2% | -$9.65K | 0.49% | 40 |
|
|
2021
Q2 | $669K | Sell |
10,014
-310
| -3% | -$20.7K | 0.56% | 35 |
|
|
2021
Q1 | $652K | Sell |
10,324
-550
| -5% | -$34.7K | 0.58% | 34 |
|
|
2020
Q4 | $677K | Buy |
+10,874
| New | +$677K | 0.64% | 29 |
|